Seelos Therapeutics
(OTC) SEELQ
Seelos Therapeutics Financials at a Glance
Market Cap
$100
Revenue (TTM)
$0.38
Net Income (TTM)
$1.71
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-236.91 (Low)
Dividend
$0.00
Beta (Volatility)
-236.91 (Low)
Price
$0.00
Volume
1
Open
$0.00
Price
$0.00
Volume
1
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
-236.91 (Low)
Price
$0.00
Volume
1
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
SEELQ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Seelos Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
16
CEO
Raj Mehra, PhD, MBA
Website
www.seelostherapeutics.comSEELQ Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
0%
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
N/A
Stock Overview
Market Cap
$100.00
Shares Outstanding
1.12M
Volume
1
Short Interest
0.00%
Avg. Volume
897.581
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Seelos Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.38
N/A
Gross Profit
$0.36
N/A
Gross Margin
96.01%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.71
N/A
EBITDA
$3.12
N/A
Quarterly Fundamentals
Net Cash
$0.29
N/A
Accounts Receivable
$0.19
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$10.16
N/A
Return on Assets
57.34%
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
$0.97
N/A
Operating Cash Flow
$0.97
N/A